Company: MBIO
Filing Date: 2025-12-03
Form Type: DEF 14A
Source: 0001104659-25-118122
Chunk: 43

Company: MUSTANG BIO, INC.
Filing Date: 2025-12-03
Form: DEF 14A
Chunk 43
---
9 Employee Stock Purchase Plan (the “ESPP”), providing for the issuance of up to an additional 250,000 shares of the Company’s common stock, $0.0001 par value per share (the “Shares”) to eligible employees, including our executive officers,and an increase in the number of shares subject to a Purchase Right thereunder to 10,000, subject to stockholder approval of the ESPP Amendment. We believe that the ESPP Amendment will benefit the Company because providing employees of the Company with an opportunity to purchase Shares should prove helpful in attracting, retaining, and motivating valued employees.

The text of the ESPP Amendment is attached to this proxy statement as Appendix A.

The following is a summary of the material provisions of the ESPP and is qualified in its entirety by reference to the complete text of the ESPP, a copy of which was filed with our proxy statement dated April 30, 2019, as Exhibit A, the Amendment to the ESPP dated June 17, 2021, a copy of which was filed as Exhibit 10.2 to our Current Report on Form 8-K, filed with the SEC on June 22, 2021, and the Amendment to the ESPP dated June 21, 2023, a copy of which was filed as Exhibit 10.1 to our Current Report on Form 8-K, filed with the SEC on June 23, 2023.

General Information

The ESPP is intended to qualify as an “employee stock purchase plan” under Section 423 of the IRC. There are currently 9,333 Shares reserved for issuance under the ESPP. The purpose of the ESPP is to attract, retain and motivate employees of the Company by permitting them to participate in the ownership of the Company. All share figures in this section give effect to the Reverse Stock Split effected on January 15, 2025.

Administration of the Plan

The ESPP is administered by our Board and/or by a committee of our Board having such power as shall be specified by our Board. Generally, each offering of common stock under the ESPP (an “Offering”) is for a period of approximately six (6) months duration (“Offering Period”). Our Board may adjust the Offering Periods, subject to certain limitations. The ESPP will continue until terminated by our Board or until all of the Shares reserved for issuance under the ESPP have been issued.

Eligibility

Participation in the ESPP is limited to eligible employees of the Company